Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-02-11 @ 2:16 AM
Study NCT ID:
NCT01837251
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2013-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Sponsor:
AGO Research GmbH